BioSante Pharmaceuticals Inc completes direct public offering

BioSante Pharmaceuticals Inc. (NASDAQ:BPAX), Lincolnshire, Ill. Business: Drug delivery, Endocrine, Genitourinary Date completed: 3/4/10 Type: Direct public offering Raised: $18 million Units: 10.4 mi...